GlassScriptPhysician profile
Matthew Chung
NPI 1821482993
$26,415.49
in general payments reported to CMS, 2019-2025
24 companies · $4,871 in 2025
The $4,871 reported for 2025 was more than what 91% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $521 · 2021: $1,170 · 2022: $4,171 · 2023: $6,530 · 2024: $9,152 · 2025: $4,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $5,562 · Consulting Fee: $3,413 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,426.94 |
| Travel and Lodging | $5,562.43 |
| Consulting Fee | $3,412.50 |
| Education | $152.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,406.58 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Saluda Medical Americas, INC. | $7,882.94 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $5,246.20 | 2020-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $1,897.29 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Spr Therapeutics, INC | $617.94 | 2021-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $437.34 | 2024-2025 | |
| Nevro Corp. | $241.60 | 2022-2023 | Senza |
| Medtronic USA, INC. | $218.06 | 2020 | |
| Globus Medical, INC. | $201.42 | 2025 | Senza, Quartex |
| Pacira Therapeutics, INC. | $172.82 | 2021 | |
| Stratus Medical, LLC | $165.29 | 2023 | Nimbus |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Averitas Pharma INC. | $135.00 | 2023 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $121.52 | 2024 | Farxiga |
| Vertos Medical, INC. | $114.12 | 2021-2023 | Mild Device Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $73.25 | 2021 | |
| Tersera Therapeutics LLC | $71.80 | 2025 | Prialt |
| Cardiovascular Systems INC. | $51.08 | 2022 | |
| Nalu Medical, INC. | $36.86 | 2022-2023 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $35.75 | 2023 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $21.94 | 2024 | Prospera |
| Abbvie INC. | $15.87 | 2025 | |
| Stryker Corporation | $15.86 | 2023 | Spinejack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.